Third degree AV block diagnostic study of choice
Third degree AV block Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Third degree AV block diagnostic study of choice On the Web | |
American Roentgen Ray Society Images of Third degree AV block diagnostic study of choice | |
Third degree AV block diagnostic study of choice in the news | |
Risk calculators and risk factors for Third degree AV block diagnostic study of choice | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2] Qasim Khurshid, M.B.B.S [3].
Overview
A 12-lead Electrocardiography (ECG) is the gold standard test for the diagnosis of third degree AV block. Nevertheless, it might be normal in patients with transient AV block. A Holter monitoring and/or telemetry must be performed when the patient presents with sign and symptoms which raising concern for complete heart block in the presence of a normal ECG. Diagnostic electrophysiologic studies might be used in certain complicated cases
Diagnostic Study of Choice
Study of choice
A 12-lead Electrocardiography (ECG) is the gold standard test for the diagnosis of third degree AV block.
Nevertheless, it might be normal in patients with transient AV block.
A Holter monitoring and/or telemetry must be performed when patient presents with sign and symptoms which raising concern for complete heart block such as:
- Syncope
- History of Heart disease
- Risk factors of Heart disease
- Elderly
- History of taking AV blocking agents
- History of heart surgery
Patients with third-degree AV block will have evidence of P wave and QRS complexes that are independent of each other. In the majority of the cases, the atrial rate will be faster than the ventricular escape rate, and there will be no association between the P waves and QRS complexes. With a very few exceptions, electrophysiologic studies are not necessary in patients with complete AV block.[1][2]
References
- ↑ Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281-2329. doi:10.1093/eurheartj/eht150
- ↑ Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published correction appears in J Am Coll Cardiol. 2019 Aug 20;74(7):1016-1018]. J Am Coll Cardiol. 2019;74(7):e51-e156. doi:10.1016/j.jacc.2018.10.044